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1. Introduction
Gastrointestinal (GI) endoscopy is defined as the direct visualization of the digestive tract,
with or without therapy. Endoscopic technology has rapidly advanced over the past 40
years and has become an integral part of clinical gastroenterology. The utilization of endos‐
copy for both diagnostic evaluation and screening has markedly increased over the last two
decades. Many innovations have expandedthe indications for endoscopy. Successful endos‐
copy relies upon the ability to recognize abnormalities and diagnose disease. It is imperative
for the endoscopist to detect GI lesions in its early stage to ensure that the patient can re‐
ceive less invasive treatment and have better prognosis. To make a correct diagnosis of early
neoplasm in the GI tract, we first need to detect any lesions with subtle morphologic change.
In this chapter we describe various GI conditions and the role of various endoscopic meth‐
ods in their diagnosis.
2. Esophagogastroduodenoscopy (EGD)
EGD is performed by passing a flexible scope through mouth to the esophagus, stomach
and duodenum. This procedure is the best method to examine upper gastrointestinal muco‐
sa can be performed under conscious sedation in most patients.
The indications for EGD are persistent upper abdominal symtoms despite trial of therapy,
upper abdominal symptoms with suspected organic disease (anorexia, weight loss etc.), dys‐
phagia, odynophagia, recurrent or persistent gastroesophageal reflux disease (GERD), per‐
sistent vomiting, familial adenomatous polyposis (FAP),GI bleeding, portal hypertension to
treat and document esophageal varices, management of achalasia/ esophageal strictures/
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stenotic lesions, removal of foreign bodies, placement of feeding tubes, palliative stenting,
surveillance of malignancy in Barrett’s esophagus, and banding of esophageal varices [1].
Contraindications  of  EGD  are  medical  instability,  patient  incooperation  and  suspected
perforation.
Complications of diagnostic EGD are cardiopulmonary events, perforation (0.03%),and
bleeding (<0.1%)[2].
2.1. Esophagus
2.1.1. Eosinophilic esophagitis
Eosinophilic esophagitis is a chronic inflammatory disease of the esophagus,usually associ‐
ated with allergic syndromes.It is increasingly diagnosed in patients presenting with episo‐
dic dysphagia and occurs predominantly in males.Endoscopically it is characterized by
longitudinal furrows (linear furrowing), widespread white spots,diffuse mucosal nodulari‐
ty,and multiple rings which fail to disappear with insufflation with air (feline esopha‐
gus).Mucosal fragility is frequent. Esophageal mucosa may bleed or become fissured with
the scope passage,particularly in the case of a small-caliber or felinized esophagus[3,4].
Figure 1. Eosinophilic esophagitis with linear furrowing and rings(pointed by arrows)
2.1.2. Pill-induced esophagitis
Prolonged contact with certain medications can irritate the esophageal mucosa causing
esophageal ulcer and esophagitis. Medication-induced esophagitis presents with sudden on‐
set of odynophagia and retrosternal pain. A clinical diagnosis may be made by history with‐
out the requirement for confirmatory endoscopy [5](19). The common culprit medications
arenon-steroidal anti-inflammatory drugs (NSAIDS), tetracyclines, bisphosphonates, potas‐
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sium chloride, and iron supplements. Endoscopyallows diagnostic confirmation and is a
more sensitive procedurethan barium swallow [5,6].
Endoscopically, pill-induced esophageal injury presents as a discrete ulcer with relatively
normal surrounding mucosa. Exudative inflammation with esophageal thickening and stric‐
ture formation are also seen.
The most common sites of injury are the proximal esophagus near the compression from the
aortic arch and the distal esophagus in patients with left atrial enlargement.It can also occur in
motility disorders which allow prolonged contact of medications with the esophageal wall [5].
2.1.3. Reflux esophagitis and Gastroesophageal reflux disease (GERD)
GERDis defined as the backward passage of stomach contents through the lower esophageal
sphincter. The symptoms of GERD include heart burn, chest pain, water brash and odynophagia.
Endoscopy at initial presentation should be considered in patients who have alarm symp‐
toms suggestive of complicated disease or those at risk for Barrett’s esophagus.These alarm
symptoms are failure to respond to appropriate antisecretory medical therapy, dysphagia,
upper GI bleeding,anemia, odynophagia, and weight loss [7].
The severity of esophageal erosions is predictive of a patient's response to therapy and of
the likelihood of relapse after therapy. Therefore it is important to grade the severity of ero‐
sive reflux esophagitis.Two grading systems which are commonly usedare Savary-Miller en‐
doscopic classification and Los-Angeles grading [7].
The Savary-Miller endoscopic classification system is used widely but usage and interpreta‐
tion are very variable. The "MUSE" (Metaplasia, Ulceration, Stricturing, and Erosions) classi‐
fication provides clear definitions of the relevant endoscopic features, and it is based on a
standardized report form, which allows the endoscopist to make a clear record of esophagi‐
tis severity.
Grade I: One or more supravestibular, non-confluent reddish spots, with or without exudates
Grade II: Erosive and exudative lesions in distal esophagus thatmay be confluent, but not
circumferential
Grade III: Circumferential erosions in the distal esophagus, covered by hemorrhagic and
pseudomembranous exudates
Grade IV: Chronic complications such as deep ulcers, stenosis, or scarring with Barrett's
metaplasia
The "L.A." (Los Angeles) classification describes four grades of esophagitis severity (A to D),
based on the extent of esophageal lesions known as "mucosal breaks," but it does not record
the presence or severity of other GERD lesions.
Grade A: One or more mucosal breaks each ≤5 mm in length
Grade B: At least one mucosal break >5 mm long, but not continuous between the tops of
adjacent mucosal folds.
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Grade C: At least one mucosal break that is continuous between the tops of adjacent mucos‐
al folds, but which is not circumferential
Grade D: Mucosal break that involves at leastthree-fourths of the luminal circumference.
Figure 2. LA grade D esophagitis
Chronic GERD can cause esophageal stricture and Barrett’s esophagus(which are described
in later sections)
2.1.4. Barrett’s Esophagus
Barrett’s esophagus is a condition in which metaplastic columnar epithelium that predispos‐
es to cancer development replaces the stratified squamous epithelium that normally lines
the distal esophagus. Barrett’s esophagus is well recognized as a complication of GERD. Pa‐
tients with GERD who develop Barrett esophagus tend to have a combination of clinical fea‐
tures, including hiatal hernia, reduced lower esophageal sphincter (LES) pressures or
delayed esophageal acid clearance time. The annual incidence of esophageal cancer in a
population of patients with Barrett’s esophagus is approximately 0.5% per year.
Endoscopically,the typical appearance of Barrett’s esophagus is a salmon pink mucosa
which extends down and joins the gastric mucosa.
The American Gastroenterologic Association (AGA) suggests endoscopic screening for Bar‐
rett’s esophagus in patients with multiple risk factors associated withesophageal adenocarci‐
noma “age 50 years or older,male sex, white race, chronic GERD, hiatal hernia,elevated
body mass index, and intra-abdominal distributionof body fat”. Once identified, patients
with Barrett esophagus should undergo periodic surveillance endoscopy to identify dyspla‐
sia.It is recommended that endoscopic evaluation be performedtaking 4-quadrant biopsies
every 2 cm with biopsy sampling of any mucosal irregularities. Four-quadrant biopsy speci‐
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mens be obtainedevery 1 cm in patients with known or suspecteddysplasia.If there is no
dysplasia surveillance endoscopy is recommended every 3-5 years.With low grade dyspla‐
sia, 6-12 month surveillance intervals are recommended. High grade dysplasia requires en‐
doscopic biopsy every 3 months if eradication therapy is not performed.The AGA
recommends endoscopic eradication therapywith radiofrequency ablation, photodynamic
therapy or endoscopic mucosal resection rather than surveillance for treatment of patients
with high-grade dysplasia with Barrett’s esophagus[8].
Figure 3. Long segment Barrett’s esophagus
2.1.5. Esophagitis related to infections
Candida
Candida species colonize in 20 % of healthy adults.The risk factors are AIDS, cancer, antibiot‐
ic or steroid therapy.The causative organism is almost always C. albicans. Candida esophagi‐
tis usually present as odynophagia or dysphagia.The diagnosis is based on the endoscopic
picture,  microscopic examination and culture of  the mucosal  brushings,  and histological
examination of the esophageal mucosa. About two-third of patients have signs of oral thrush
(thus its absence does not exclude esophageal involvement).EGD with brushings orbiopsy is
currently the most sensitive and specific method of diagnosis.Endoscopy demonstrates pat‐
chy, whitish plaques covering a friable, erythematous mucosa.When the infection is severe,
ulceration may be present as well [9]. Confirmatory biopsy shows the presence of yeasts and
pseudohyphae invading mucosal cells, and the culture reveals Candida.
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Figure 4. Pale plaques with erythematous mucosa – esophageal candidiasis
Herpes simplex virus
HSV-1 infection of the esophagus is usually seen in immunocompromisedconditions such
asorgan or bone marrow transplantation. Less commonly in HIV patients and occasionally
immunecompetent patients acquire HSV-1 infection. Endoscopically, there are well circum‐
scribed ulcers with raised margins and a punched out” appearance,distinguishing them
from the ulcers seen in CMV infection.Exudates, plaques, or diffuse erosive esophagitis and
vesicles can also be seen. Biopsies should be taken from the edge or margin of the ulcer
where viral cytopathic effects are most likely to be present [10].
Cytomegalovirus
The most common cause of esophagitis in patients with advanced AIDS is Candida, whereas
the most common viral cause is CMV. CMV esophagitis is seen in post-transplantation,
long-term renal dialysis, human immunodeficiency virus (HIV) infection, and AIDS and
other debilitating diseases. Endoscopically,extensive ulceration of the esophagus is hallmark
of CMV esophagitis.It may present as asolitary ulcer or multiple ulcers.Most ulcers are not‐
ed in the distal esophagus [11]. The multiple biopsy specimens should be taken from the
base of the ulcer.
2.1.6. Esophageal diverticulum
The formation of diverticula occurs due pulsion from increased intraluminal pressure result‐
ing in pushing of esophageal mucosa andsubmucosa through the focal weakness of mucosal
wall. The risk factors are esophageal dysmotility or stricture which contribute to intralumi‐
nal pressure[12].Esophageal diverticula are rare but can occur in any part of the esopha‐
gus.If it occurs in the upper esophagus above the upper esophageal sphincter through a
weak spot (Killian’s triangle)form above the upper esophageal sphincter in the midline pos‐
teriorly at the pharyngoesophageal junction, it is called Zenker’s diverticulum. When it oc‐
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curs in the distal esophagus just abovethe lower esophageal sphincter, it is called epiphrenic
diverticula. Endoscopically appear round with a wide neck.
Endoscopy does not play important role in the diagnosis but the endoscopistshould be
aware and cautious about their presence as perforation can occur with endoscopy especially
when side viewing scopes are used. Esophageal diverticula are well seen on barium x-ray
examination, which is the best modalityfor diagnosis.
2.1.7. Esophageal rings and webs
Esophageal  webs  are  thin  membrane  like  structure  containing  mucosa  and  submucosa
which can occur anywhere in the esophagus.The patients are asymptomatic or have only
intermittent dysphagia. It is frequently discovered incidentally during radiographic stud‐
ies  for  other  reasons.  However,  esophageal  webs have been described in  Plummer-Vin‐
son  syndrome  which  present  as  iron  deficiency  anemia,  glossitis  and  koilonychia.
Endoscopically, the webs are seen with difficulty due to proximal location.They are cov‐
ered with squamous mucosa [13,14].
Esophageal rings are thin, fragile structures that partially or completely obstruct the esoph‐
ageal lumen.They present with dysphagia if the lumen is <13 mm. They are usually seen in
the distal  esophagus.  If  the ring occurs at  squamocolumnar junction covered with squa‐
mous mucosa above and columnar epithelium below, it is called Schatzki ring or Type B
ring. If the ring occurs about 1.5 cm proximal to the squamocolumnar junction, it is called
Type A ring. Endoscopy is less sensitive than the barium esophagram in detecting esopha‐
geal rings [13,14].
Endoscopically, an esophageal ring appears as a thin membrane with a concentric smooth
contour that projects into the lumen.
Figure 4. Schatzki ring
Diagnostic Endoscopy
http://dx.doi.org/10.5772/ 52826
43
Figure 5. Esophageal web
2.1.8. Stricture
The esophageal stricture is narrowing of esophagus which can be benign or malignant.The
symptoms of esophageal stricture are usually insidious but progressive with dysphagia to
solids followed by dysphagia to liquids. Dysphagia corresponds to the caliber of the stric‐
ture; dysphagia to solids is usually present when the esophageal lumen is narrowed to 13
mm or less. The causes of esophageal stricture formation are GERD, long-term use of a naso‐
gastric (NG) tube, complication of sclerotherapy for varices, infectious esophagitis, post sur‐
gical resection for esophageal or laryngeal cancer, caustic ingestion, pill esophagitis, and
radiation exposure [15].
Endoscopy is helpful as it allows direct visualization, tissue sampling to rule out malignan‐
cy, and dilation of the narrowed part of the esophagus.
Figure 6. Esophageal stricture
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2.1.9. Hiatus hernia
Hiatus hernia refers to herniation of elements of the abdominal cavity most commonly
stomach,into the mediastinum, through the esophageal hiatus of the diaphragm.Endoscopic
and radiographic studies have shown a significant relation between GERD and hiatal hernia
[16]. The main types of hiatal hernia are sliding type and para-esophageal type.
Sliding hiatal hernia accounts for more than 95 % of cases. It is characterized by widening of
the muscular hiatal tunnel and circumferential laxity of the phrenoesophageal membrane,
allowing a portion of the gastric cardia to herniate upward. Hiatal hernias that are larger
than 2 cm in axial span can be diagnosed easily by barium swallow radiography, endos‐
copy, or esophageal manometry. Smaller hernias are more difficult to define. Endoscopical‐
ly, the squamocolumnar junction appears 2-3 cm above the diaphragmatic hiatus. On
endoscopic retroflexed view appears as pouch like area just below mucosal junction and
above the diaphragm [17].
Figure 7. Sliding hiatal hernia visible in the esophagus
Para-esophageal herniasaccount for about 5 % of all hiatal hernias.Anatomically,the pouch
of stomach herniatesinto the chest adjacent to the esophagus.Most complications of a para-
esophageal hernia are related to mechanical problems caused by the hernia. Para-esopha‐
geal hernias are best diagnosed with a barium swallow, although their presence is usually
suggested by endoscopy.Endoscopically, they can cause difficulty in locating the main gas‐
tric lumen.
Cameron lesions are erosions or ulcers occurring in the sac of a hiatal hernia. They have
been described in up to 5.2 % of patients with a hiatal hernia who undergo upper endos‐
copy. They are usually an incidental finding but rarely cause acute or chronic upper gastro‐
intestinal bleeding and iron deficiency anemia[18].
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2.1.10. Motility disorders of the esophagus
Motility disordersin the esophagus present as dysphagia. Evaluation of esophageal motility
disorders often begins with endoscopy.The diagnosis can be made with endoscopy alone,
however some cases require manometry or barium swallowing study for confirmation.
Endoscopy typically reveals a dilated esophagus in achalasia that often contains residual
material. A‘‘popping’’effect with difficulty in passing the endoscope through the gastro-
esophageal junction may be noted.The esophageal mucosa usually appears normal. Endos‐
copy is also essentialin achalasia to exclude malignancy.
Endoscopic findings in spastic disorders of the esophagus such as nutcracker esophagus and
diffuse esophageal spasm are often normal; however, it may reveal sacculations, diverticula,
and chaotic contractile activity along the mid or distal esophagus.Endoscopyis usually per‐
formed to exclude structuralesophageal obstruction.
In scleroderma, endoscopic findings usually relate to a hypotensive lower esophageal sphinc‐
ter [12].
2.1.11. Other benign lesions of the esophagus
The prevalence of benign esophageal tumors is 0.5%. The majority of these benign tumors are
asymptomatic which diagnose incidentally. Dysphagia is the most common presenting symp‐
tomin patients with symptomatic benign esophageal tumors which occurs with large sized
tumors. Other symptoms include regurgitation, vomiting and retrosternal discomfort [19].
Leiomyomas
Leimyomas are the most common benign tumors of the esophagus. They arise from smooth
muscle cells. Dysphagia can occur only with large sized tumors. Endoscopically, they ap‐
pear as submucosal masses with smooth margins and normal overlying mucosa.
Esophageal Cyst
Esophageal cysts are second most common benign tumors. Cysts are usually located in the
upper esophagus and are lined by ciliated columnar epithelium. Endoscopically, they ap‐
pear as protruding mass in the lumen. Surgical resection is required as they can cause com‐
plication line obstruction or hemorrhage.
Fibrovascular polyps
Fibrovascular polyps are thin, solitary polyps which usually occur in upper esophagus.
They present with symptomatic dysphagia. Over 75 % are 7cm or larger. They have large
mucosal folds or large pedicles containing blood vessel.
Squamous cell papilloma
Squamous cell papilloma is usually solitarysessile, warty lesion less than 1.5cm occurring
most commonly in lower third of the esophagus.Histologically they are finger like projec‐
tions of hyperplastic squamous tissue. Etiology of these lesions is felt to be due to human
papillomavirus (HPV) infection.
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Inlet patch
Inlet patch is isolated area in the esophagus resembling gastric mucosa usually found in the
proximal esophagus.It can be associated with Barrett’s esophagus and esophagitis in about
20% cases. Histologically, oxyntic type gastric mucosa is most commonly seen [20].
Figure 8. Inlet patch in the esopghagus
Glycogen acanthosis
Glycogen acanthosis presents as elevated gray-white plaques in the esophagus that range in
diameter from 1 to15 mm. They are seen in 20–40% of endoscopic procedures and are more
prominent in the lower third of the esophagus. Histologically, the epithelium is thickened
by the proliferation of large squamous cells filled with glycogen. Glycogen acanthosishas
been associated with Cowden’s syndrome and celiac disease.
2.1.12. Foreign bodies of the esophagus
Ingestion of foreign bodies occursmost commonly among those with psychiatric disorders,
mental retardation, prisoners, and alcoholics.Thepresence of esophageal stricture or ring
predispose to impaction of foreign body or food bolus in the esophagus. Fortunately, most
pass through the gastrointestinal tract harmlessly. However, 10–20% will require non-opera‐
tive intervention. Endoscopic extraction is themainstay of non-operative interventions
which usually attempt after radiographic localization. Foreign bodies at the level of the hy‐
popharynx or cricopharyngeus muscle are best treated with rigid laryngoscopy using a
grasping clamp.In all other cases esophagoscopy is the method of choice [21].
2.1.13. Esophageal Varices
Varices are dilated veins which develop in the esophagus and stomach due to portal hyper‐
tension. Severe upper GI bleeding from varicesas a result of portal hypertension develops in
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about 30-40%of cirrhotic patients. Mortality of the first variceal bleed is 25-35%. Endoscopic
grading of size and stigmata is very important in predicting the risk of hemorrhage.Endo‐
scopic stigmata which are associated with risk of variceal hemorrhage are red wale mark‐
ings, white nipple sign, cherry red and hematocystic spots andvariceallarge size [22]. It is
recommended that all the patients with cirrhosis have a screening test to determine presence
of varices, so that preventive treatments can be recommended to prevent bleeding [23].
Endoscopically, esophageal varices are graded according to their size, as follows [24]:
Small (Grade 1): Small straight varices
Medium (Grade 2): Enlarged tortuous varices occupying less than one third of the lumen
Large (Grade 3): Large coil-shaped varices occupying more than one third of the lumen.
Upper endoscopy plays vital role in diagnosis, management, screening and surveillance of
esophageal varices.
Figure 9. Grade 2 esophageal varices
2.1.14. Mallory Weiss Tear
Mallory Weiss tear is a mucosal lacerationat the level of gastroesophageal junction or gastric
cardia usually caused by forceful emesis or retching. Most tears occur with in 2 cm of the
cardia side of the gastroesophageal junction on the lesser curvature. The majority of patients
present with gastrointestinal bleeding. Endoscopy is the diagnostic test of choice which also
helps in allowing visualization of any active bleeding. Usually,a single tear is noted and the
most common location is the right posterior aspect of the cardia. Between 2 and 6 O’clock
position with patient in left lateral decubitus position. If endoscopy is delayed, a healing
tear may be seen with grayish or erythematous granulation tissue [25].
Endoscopy of GI Tract48
Figure 10. Mallory Weiss Tear at GE junction (pointed by the arrow)
2.1.15. Esophageal neoplasm
Carcinoma of the esophagus presents with dysphagia to solid food usually which progress‐
es gradually to both solids and liquids.There are two main types of esophageal carcinoma:
squamous cell type and adenocarcinoma.
Squamous cell carcinoma presents as three typical forms
polypoid mass (most common),
mass with central depressed ulceration,and
diffuse infiltrating form associated with malignant stricture.
Adenocarcinoma usually appears as an infiltrative lesion, with a narrowed lumen with or
without associatedmass. It often has a nodular appearance with friable and eroded mucosa;
stricture may occur.
Endoscopic visualization with multiple biopsies to increase diagnostic yield must be per‐
formed to confirm the diagnosis. Chromoendoscopy using Lugol’s iodine (discussed later) is
helpful to direct the biopsies and identify the disease extent. Endoscopic ultrasound along
with PET /CT further defines the extent of the disease.
2.2. Stomach and duodenum
2.2.1. Peptic ulcer disease
Endoscopy is the most accurate diagnostic test for peptic ulcer disease (PUD) which could
be benign or malignant ulcers.
Benign Ulcer
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Benign ulcers have smooth, regular, rounded edges, with a flat, smooth ulcer base often fil‐
led with exudates.The ulcer base is white covered by fibrinous granulation tissue.In the
event of recent bleeding, stigmata of recent bleeding can be seen in the ulcer base.
Figure 11. Large cratered clean based gastric ulcer
Malignant ulcer
An ulcerated mass with nodular looking folds and irregular overhanging, nodularmargin is
suggestive of malignant ulcer. The chance of malignancy is greater in large gastric ulcers.In
about 20 % of cases, endoscopic appearance cannot distinguish benign from the malignant
ulcer. 4-6 biopsies of the ulcer margin are shown to detect the vast majority of cancers. Mul‐
tiple endoscopic biopsies of even benign-appearing gastric ulcerations should be performed
due to the risk they may harbor malignancy [26].
Refractory ulcers
Refractory ulcers have been defined as those that fail to heal despite 8 to 12 weeks of antise‐
cretory therapy.I n patients with refractory PUD, surveillance endoscopy should be consid‐
ered until healing is documented or until the etiology is defined (eg. NSAID use, highgastrin
states, ischemia).
Bleeding ulcers
Endoscopy is an effective tool in the diagnosis, prognostication, and management of ulcer
bleeding. Randomized studies have shown early endoscopic interventions (within 24 hours
of admission) reduce blood transfusionr equirements, shorten intensive care unit and hospi‐
tal stays, decrease need for surgery, and lowermortality rate [27]. Patients who are hemody‐
namically stable with endoscopy revealing ulcers without high-risk stigmata may be safely
discharged home after endoscopy. Patients with endoscopic stigmata indicating a high risk
of rebleeding which includes adherent clots, visible vessels, and active arterial bleeding
should all undergo endoscopic therapy to achieve hemostasis and reduce the risk of rebleed‐
ing. Recurrent bleeding may occur in as many as 10% of patients despite endoscopic therapy
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and the use of high-dose proton pump inhibitors. In patients who rebleed after initial endo‐
scopic therapy, repeat endoscopic therapy is suggested before considering surgicalor radio‐
logic intervention [28].
2.2.2. Gastric outlet obstruction
Gastric outlet obstruction may occur as a result of PUD with inflammation and scarring of the
pylorus or duodenum. Patients typically present with loss of appetite, epigastric pain, bloat‐
ing, nausea, vomiting, and weight loss. Endoscopy is important in confirming the diagnosis
and differentiating benign from malignant obstruction. Active ulcers may be noted in associ‐
ation with gastric outlet obstruction in as many as one third of patients undergoing endos‐
copy for this condition [29]. Biopsies to excludem alignancy should be considered.
2.2.3. Gastritis and gastropathy
Gastritis is an inflammatory process while gastropathy demonstrates minimal to no inflam‐
mation.
Gastritis
Gastritis is a term that covers entities that induceacute inflammatory changes in the gastric
mucosa. The inflammation may involve the entire stomach or a region of the stomach. Acute
gastritis is classified as erosive or non-erosive. Erosive gastritis appears as superficial, deep
or hemorrhagic erosions. Non erosive gastritis generally caused by Helicobacter pylori.
Vascular gastropathy
Vascular gastropathies are abnormalities in the gastric tissue that involve mucosal vessels
with or without inflammation. The two most important vascular gastropathies are gastric
antral vascular ectasias(GAVE) and portal hypertensive gastropathy (PHG).
GAVE is characterized by longitudinal columns of vascular ectasias that cross the antrum and
converge on the pylorus.The columns have the appearance of the outside of a watermelon.
Thus, this disorder commonly being referred as” water melon stomach” [30]. Histpathologi‐
cal exam shows minimal inflammation in the lamina propria, but there is prominent fibromus‐
cular hyperplasia with dilated muscular capillaries. It is common in females and is associated
collagen vascular disease and liver disease. It can lead to iron deficiency anemia and the patient
may become transfusion dependent. GAVE can be treated with endoscopic therapy using
argon plasma coagulation.
Portal hypertensive gastropathy (PHG) or (congestive gastropathy) is a rare cause of signifi‐
cant upper GI bleeding in patients with portal hypertension. PHG characteristically appears
as a fine white reticular pattern separating areas of pinkish mucosa on endoscopy, giving the
gastric mucosa a "snakeskin" appearance. The vascular abnormalities involve deeper submu‐
cosal vessels that are dilated, irregular and tortuous. Patients with severe PHG may develop
iron deficiency anemia due to active oozing requiring blood transfusions. Since deeper ves‐
sels are involved endoscopic treatment is not effective. Treatment is aimed at
1. decreasing portal pressure with beta blockers,
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2. portal decompression withtransjugular intrahepatic portosystemic shunt (TIPS), or
3. liver transplantation.
Hypertrophic Gastropathy
Gastric mucosal hypertrophy refers to giant gastric folds. Diffuse mucosal hypertrophy may
be described as hyperplastic or nonhyperplastic.In hyperplastic gastropathy gastric epithe‐
lial cells which compose the oxyntic glands may become hyperplastic and give rise to giant
mucosal folds. The conditions include: Ménétrier's disease, hyperplastic hypersecretorygastr‐
opathy, and Zollinger-Ellison syndrome. In nonhyperplasticgastropathy - gastric mucosa may
contain other cell types which result in enlargement of the gastric folds. These conditions
include infiltrative diseases, infections, and malignancy.
Endoscopy with mucosal biopsy is required to distinguish between acute, chronic active and
chronic gastritis and gastropathy. All gross abnormalities should be biopsied withmultiple
biopsies of both the corpus and the antrum to establish the diagnosis of Helicobacter pylori
or autoimmune gastritis.Biopsies of the duodenum may also be helpful for diagnosing some
forms of chronic gastritis such as Crohn’s disease in patients with granulomatous gastritis and
celiac disease in patients with lymphocytic gastritis [31].
2.2.4. Dieulafoy’s lesions
Dieulafoy's lesion is a rare but important cause of upper GI bleeding. Arterial bleeding from
an aberrant vessel isvisualized without an associated ulcer or mass lesion.The lesion can be
easily missed on endoscopy in the absence of active bleeding. It may look like a raised nipple
or visible vessel without an associated ulcer. Endoscopy is the diagnostic modality of choice
for a Dieulafoy's lesion during acute bleeding [32].
Figure 12. Actively bleeding dieulafoy’s lesion
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2.2.5. Gastric polyps
Gastric polyps are usually found incidentally when upper GI endoscopy performed for an
unrelated indication. They are important since some types of polyps have malignant poten‐
tial [33]. Adenomatous gastric polyps are at increased risk for malignant transformation and
should be resected completely. Hyperplastic polyps have a rare malignant potential. Endo‐
scopic polyp appearance cannot differentiate histologic subtypes, therefore biopsy or poly‐
pectomy is recommended when a polyp is encountered. When multiple gastric polyps are
encountered, a biopsy of the largest polyps should be performed or they should be excised.
Surveillance endoscopy 1 year after removing adenomatous gastric polyps is reasonable to
assess recurrence at the prior excision site, new or previously missed polyps, and/or super‐
vening early carcinoma. If the results of this examination are negative, repeat surveillance
endoscopy should be repeated no more frequently than at 3- to 5-year intervals. Follow-up
after resection of polyps with high-grade dysplasia and early gastric cancer should be indi‐
vidualized. No surveillance endoscopy is necessary after adequate sampling or removal of
non-dysplastic gastric polyps [34].
The various types of gastric polyps are briefly described below.
Fundic Gland Polyps
Fundic gland polyps are the most common type of polyps detected by endoscopy. These le‐
sions are typically less than 5 mm in size, sessile and smooth in appearance. They are locat‐
ed in body and fundus. Fundic gland polyps are commonly seen in patients who take
proton pump inhibitors (PPIs) on a long-term basis. They have an extremely low malignant
potential. The PPI-related lesions may regress in 3 months, once use of the PPI is discontin‐
ued. A polyp associated with familial polyposis carries a defined 30% to 50% risk of devel‐
oping dysplasia. When multiple fundic gland polyps are evident in younger patients,
evaluation for familial polyposis should be considered.Biopsy of fundic polyps is done to
exclude dysplasia [35].
Hyperplastic polyps
Hyperplastic polyps are caused by an inflamed or atrophic gastric mucosa. They have a
smooth, dome-shaped appearance. Hyperplastic polyps can be large in size, and patients
may present with chronic blood loss or even gastric obstruction. Elimination of the underly‐
ing cause, such as H pylori infection, typically results in polyp regression. The risk of malig‐
nancy is higher if polyps exceed 2 cm in size. For this reason, large polyps must be
completely excised.
Adenomatous Polyps
Adenomatous polyps occur sporadically or in association with familial polyposis. Thesepo‐
lyps are circumscribed, pedunculated, or sessile. They are associated with chronic atrophic
gastric metaplasia and have a defined cancer risk. Complete removal should be performed.
Polyposis Syndromes
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Polyposis syndromes are characterized by multiple polyps.They include juvenile polyposis,
Cronkite-Canada syndrome, Peutz-Jeghers syndrome, and Cowden's disease. Hamartoma‐
touspolyps may be present in all of these syndromes. Adenomatous polyps may be found in
familial polyposis.
Gastrointestinal Stromal Tumor
Gastrointestinal stromal tumors (GISTs) make up 1% to 3 % of gastric neoplasms and occur
more frequently in men than in women. GISTs are typically located in the fundus. Biopsy is
typically normal. Endoscopic ultrasonography-guided biopsy with fine-needle aspiration
provides the best tissue sample for diagnosis. GISTs are categorized as having malignant
potential ranging from low risk to high risk on the basis of polyp size and level of mitotic
activity. All GISTs should be regarded as having neoplastic potential. Surgical resection is
recommended for lesions larger than 2 cm. Endoscopic resection is an option for smaller
GISTs [35].
Pancreatic Heterotopia
Pancreatic heterotopia may present assubmucosal nodular involvement (single or multiple)
at the esophagogastric junction or as asubmucosal nodular lesion located in the antrum and
prepyloric area.There is a characteristic nodule with a central dimple is seen endoscopically.
Histological features resemble normal pancreatic tissue.Pancreatic heterotopia is a benign
and asymptomatic condition.
2.2.6. Gastric neoplasm
Esophagogastroduodenoscopy has a diagnostic accuracy of 95% in diagnosing gastric can‐
cer. Early gastric cancers may appear as a subtle polypoid protrusion, superficial plaque,
mucosal discoloration, depression, or ulcer [33]. Improved detection of abnormal lesions
may be possible with chromoendoscopy, narrow band imaging and magnification endoscop
y(discussed later). Endoscopy is also the primary method for obtaining a tissue diagnosis of
suspected lesions. Biopsy of any ulcerated lesion should include at least 6 specimens taken
from around the lesion because of variable malignant transformation.The early use of upper
endoscopy in patients presenting with gastrointestinal complaints may be associated with a
higher rate of detection of early gastric cancers. During endoscopy, any suspicious-appear‐
ing gastric ulceration should be biopsied. The diagnosis of anaggressive form of diffuse-type
called "linitisplastica", can be difficult endoscopically. Because these tumors infiltrate the
submucosa and muscularispropria, superficial mucosal biopsies may be falsely negative.
In selected cases, endoscopic ultrasound may be helpful in assessing depth of penetration of
the tumor in the layers of the stomach or involvement of adjacent structures.
3. Push enteroscopy
The evaluation of small intestine is difficult due to its length, intraperitoneal location and
tortuousity. Recent developments of push enteroscopy, balloon assisted endoscopy, and
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capsule endoscopy have made endoscopic examination of the entire small bowel examina‐
tion practical. Methods used to evaluate the small bowel include push enteroscopy, single
balloon, double balloon enteroscopy and wireless capsule endoscopy [36].
Push enteroscopy using the enteroscope or pediatric or adult colonoscope allows evaluation
of small bowel 70-150 cm beyond ligament of Treitz. The disadvantage is looping of scope
resulting in patient discomfort. It helps in diagnosis and therapeutics in small bowel lesions
in the proximal small bowel [36].
4. Deep small bowel enteroscopy
Diagnostic indications for deep small bowel enteroscopy include obscure gastrointestinal
bleeding, tattooing of suspected small bowel malignancies or abnormal findings on other
imaging studies and wireless capsule endoscopy, suspected nonsteroidal anti-inflammatory
drug-induced small bowel injury, suspected or established small bowel Crohn's disease, re‐
fractory celiac disease,detection of polyps in patients with polyposis syndromes such as
familial adenomatous polyposis or Peutz-Jeghers syndrome, examination of the gastric rem‐
nant in patients who have undergone Roux-en-Y gastric bypass and removal of foreign bod‐
ies like retained wireless capsule [37,38].
Deep small bowel enteroscopy can be performed with balloon-assisted or spiral enterosco‐
py. Single and double balloon techniques are described. These techniques allow deeper ac‐
cess to the small bowel than push enteroscopy.
Single balloon enteroscopy (SBE) uses the scope’s flexible tip to anchor the scope to the bow‐
el and intestinal tract is pleated over the overtube and shortened.On the other hand double
balloon uses a second balloon to anchor the bowel instead of the scope tip.The working
length of double balloon endoscope (DBE) is about 150-200 cm as a result 150-350 cm of
small bowel can be visualized. The success rate of complete inspection of small intestine is
40-80%.Balloon-assisted enteroscopy (ie, DBE and SBE) which can be performed orally or
per rectum, where as spiral enteroscopy can only be performed orally. The complications of
double balloon enteroscopy are ileus, pancreatitis, perforation and prolonged duration of
procedure [38].
Spiral enteroscopy is a diagnostic and therapeutic intervention of the small bowel. A small
enteroscope is used with overtubethat has helical spirals on the surface. The overtube slides
over the enteroscope.There are no major complications reported.The limitations are in‐
creased sedation requirement [36].
5. Wireless capsule endoscopy
Wireless capsule endoscopy is an ambulatory procedure which has become a first line test
for visualizing the mucosa of the small intestine.The PillCam is a capsule comprise of a lens
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imager, battery and transmitter. The capsule moves from mouth to the anus with peristalsis
taking two images per second at 1:8 magnification. The PillCam SB is FDA approved for vis‐
ualization of the small bowel mucosa in adults and children aged >10 years(4).
The most  common indications include evaluation of  obscure GI bleeding including iron
deficiency anemia, suspected Crohn’s Disease, small intestinal tumors and surveillance in
patients with polyposis syndromes,refractory malabsorptive syndromes (eg, Celiac disease)[39].
Contraindications suspected GI obstruction, gastroparesis, swallowing disorders, pregnan‐
cy, dementia, strictures or fistulas (based on the clinical picture or preprocedure testing),
cardiac pacemakers or other implanted electro-medical devices.
5.1. Small intestine
5.1.1. Celiac disease
Celiac disease is a condition in which the immune system responds abnormally to a protein
called gluten causing damage to the lining of the small intestine.It affects about 1% of the
western population.Patients with celiac disease usually have positive IgA endomysial or‐
transglutaminase antibody.Patients with positive antibodies should undergo endoscopy
with small bowel biopsy.
The duodenal mucosa may appear atrophic with loss of folds, contain visible fissures, have
a nodular appearance or the folds may be scalloped. Multiple biopsies should be obtained in
the second and third portion of the duodenum by upper GI endoscopy. Staining techniques
and high resolution magnification endoscopy canalso help identify areas of villous atrophy
for biopsy (discussed later) [40]. Videocapsule endoscopy shows good sensitivity and excel‐
lent specificity for the detection of villous atrophy in patients with suspected celiac disease
[41]. The advantages of video capsule endoscopy (VCE) are that it is noninvasive, it images
the entire length of the small bowel, and it is able to detect minute mucosal details. For these
reasons VCE may be a useful tool for the diagnosis of Celiac disease [42].
5.1.2. Crohn’s disease
Crohn's disease is characterized by transmural inflammation of the gastrointestinal tract.
Crohn's disease may involve the entire gastrointestinal tract from mouth to the perianal area.
It mostly affects distal small bowel and right colon and 20-30% have disease limited to the
small bowel only. Thus colonoscopy with ileoscopyand biopsy is a very important test in the
diagnosis of Crohn's disease. It can be diagnosed by upper endoscopy, enteroscopy, wire‐
less capsule endoscopy or colonoscopy with terminal ileum intubation based on the location
of GI tract involvement. Capsule endoscopy and double balloon enteroscopy have compara‐
ble yield. Therefore, capsule endoscopy may be part of an initial evaluation followed by double
balloon enteroscopy if biopsy or intervention is needed [43]. Capsule retention is the main and
only complication which is indefinite presence of capsule which occurs most commonly in
patients of known Crohn’s disease [39]. This can be avoided by the use of patency capsule
(disintegration time-controlled capsule) in patients with high risk of capsule retention [44].
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Figure 13. Crohn’s disease ulcer in the colon (pointed with an arrow)
On enteroscopy,the findings inCrohn's Disease are linear ulcers,aphthous ulcers,round or ir‐
regular ulcers,pseudopolyps,cobble stoning, stricture or stenosis.
5.1.3. Tumors of small bowel
Tumors of the small bowel are relatively uncommon andaccount for approximately 3% of
gastrointestinal neoplasms. As the symptoms are vague and conventional diagnostic tests
are unsatisfactory.These tumors often present a clinical, radiological, and endoscopic chal‐
lenge. Endoscopy is very accurate in diagnosing and identifying small bowel lesions[45].
Capsule endoscopy is helpful in the diagnosis of small bowel tumors[46]. Double balloon
endoscopy is shown to have good diagnostic capabilities due to its ability to take biop‐
sies[47]. However, isolated mass lesions can be missed on incomplete balloon endoscopy or
capsule endoscopy[48]. The clinical conditions that predispose to small bowel neoplasms are
Familial adematous polyposis, hereditary non-polyposis colorectal cancer (HNPCC), Peutz-
Jegherssyndrome, celiac disease, and Crohn’s disease[45].
Adenocarcinomas are the most common type of primary malignant small bowel tumors
mostly occurring in duodenum.They appear as circumscribed,polypoid usually large and
circumferentially involving the bowel wall.
Carcinoids mostly occur in the terminal ileum,less than 1 meter from IC valve. They are usu‐
ally small and found incidentally.
GISTs appear as dome shaped submucosal with central ulceration, commonly seen in jejunum.
6. Colonoscopy
Colonoscopy is endoscopic visualization of colonic mucosa.A complete exam is possible in
95-99% of patients.The main indications to colonoscopy are screening and surveillance for
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colon polyps, pathological bowel wall thickening notedon imaging procedures,diarrhea,
malabsorption, rectal bleeding,unexplained iron deficiency anemia, positive fecal occult
blood test,suspected short strictures of the colon,rectal foreign bodies,weight loss and ab‐
dominal pain [49]. The contraindications of colonoscopy are peritonitis, perforation, fulmi‐
nant colitis and recent surgical anastomosis.
Complications of colonoscopy are perforation (0.2% with diagnostic colonoscopy and 0.32%
with polypectomy), hemorrhage (0.09% with diagnostic colonoscopy and 1.7% with poly‐
pectomy) and postpolypectomy coagulation syndrome( electrocoagulation injury inducing
transmural burn in 0.5-1.2%,occurs 1-5 days of polypectomy, requires no surgical interven‐
tion) and sedation related complications [50]. Thus, polypectomy is the single greatest risk
factor for complications of colonoscopy.
6.1. Colon
6.1.1. Screening colonoscopy
Screening for colorectal cancer with colonoscopy is the most common procedure performed
by gastroenterologists in the US. Identification of premalignant polyps is primary goal.Some
polyps are only hyperplastic with minimal malignant potential. Polyps of concern are called
adenomas which are premalignant. Guidelines recommend colonoscopy every 10 years be‐
ginning at age 50 years. The follow up colonoscopy should be based on number, size and
pathologic findings of the adenomatous polyps removed. Patients with 1-2 small (<1cm) tub‐
ular adenomas with only low grade dysplasia should get follow up after 5 years, whereas
patients with 3 or more or advanced adenomatous lesions should get repeat colonoscopy in
3 years or before if colonoscopy was incomplete, preparation was poor or >10 polyps are re‐
moved.If surveillance colonoscopy is normal, follow up colonoscopy is recommend after 5
years. Patients with large,sessile adenomatous lesions which are removed in piecemeal
should have repeat examination within 2-6 months to exclude and remove remnant poly‐
poid tissue [51].
6.1.2. Colonic polyps
Colonic polyps are benign neoplasms that arise from the epithelial cells lining the colon. Colonic
polyps are divided into 3 groups: hyperplastic polyps, adenomas, and polyposis syndromes [52].
Hyperplastic polyps
Hyperplastic polyps comprise about 90% of all polyps. They are rounded and sessile meas‐
uring few millimetersin size and cannot be distinguished from adenomas. Hyperplastic pol‐
yps most commonly occur in the rectosigmoid region.Theylack malignant potential
especially if they are located in the rectosimoid area and if the size is few mm. Malignant
potential is present only in the setting of very large polyps.
Polyps with architecture similar to hyperplastic polyps but the cytology is different with
surface mitotic activity, higher nuclear /cytoplasmic ratio and serrated glandular pattern as
a result they are termed as “serrated adenomas”[52]..
Endoscopy of GI Tract58
Figure 14. Stalked colon polyp
Adenomas
Adenomas can be seen throughout the colon.Most(70%) found in the left colon and are
<1cm.Three histological subtypes are described: tubular, villous and tubulovillous.Tubular
adenomas are the most common and can be found anywhere in the colon. Villous adenomas
most commonly occur in the rectal area,larger than the other two types, and tend to be non‐
pedunculated, velvety, or cauliflower-like in appearance. They are more likely to harbor car‐
cinoma in situ or invasive carcinomacompared toother adenomas.The risk of progression to
carcinoma is related to both the size and the histology of the adenoma. Adenomas that are
greater than 1 cm with villous component carry an increased cancer risk.
The shape or gross structure of the polyp is also clinically significant.Polyps with a stalk are
called pedunculated. Those polyps without a stalk are called sessile. Sessile polyps are more
concerning than large pedunculated polyps for two reasons. First, the pathway for migra‐
tion of invasive cells from the tumor into submucosal and more distant structures is shorter.
Second, complete endoscopic removal is more challenging and more difficult to accomplish.
Premalignant flat lesions are now more readilydetected by new endoscopic imaging meth‐
ods, such as narrow-band imaging or mucosal staining (described later). The colon polyps
are removed with snare cautery, cold biopsy,hot biopsy or cold snaring [53].
6.1.3. Inherited syndromes
Familial adenomatous polyposis(FAP) is an autosomal dominant condition in whichat least
100 adenomatous polyp in the colon, most numerous in the distal colon. When left untreated
these polyps develop into colon cancer by third to fifth decade [52].
Hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome is a misnomer as
these patients have adenomas similar to general population. However, the adenomas ap‐
pear at younger age and presents with early on set of colorectal cancer before the age 40,
mostly in the right colon. There can be metachrnous or synchronous colorectal malignancies,
associated with tumors of other organs especially endometrium, ovary and stomach.
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Peutz-Jegherssyndrome is characterized by the presence of hemartomatous polyps occur‐
ring more frequently in the small bowel and colon. Melanin spots may be seen on lips and
buccal mucosa.These polyps are not precancerous but patients are prone for tumors of
breast, lung, ovary and pancreas.
Juvenile polyposis is a conditionpresenting with hamartomatous polyps in the colon, stom‐
ach  and  small  bowel.  These  polyps  may  be  precancerous  andrequire  close  endoscopic
surveillance.
6.1.4. Ischemic Colitis
Ischemic colitis is the most frequent form of mesenteric ischemia, presenting with sudden
onset of abdominal pain followed by bloody diarrhea. Colonoscopy or sigmoidoscopy is of‐
ten required to establish the diagnosis of ischemic colitis. The examination usually per‐
formed without bowel preparation (to avoid reducing blood flow from dehydrating
cathartics), and with minimization of air insufflation (to avoid distention and perforation).
Colonoscopy is more sensitive in detecting mucosal lesions allows biopsies, and does not in‐
terfere with subsequent angiography.
Colonoscopic findings in the acute setting frequently include pale mucosa with petechial
bleeding withbluish hemorrhagic nodules may be seen representing submucosal bleeding
[54]. Cyanotic mucosa and hemorrhagic ulcerations are seen later in the course [55]. Seg‐
mental distribution, abrupt transition between injured and non-injured mucosa and rectal
sparing favor the diagnosis of ischemic colitis [54].
Figure 15. Ischemic colitis
Endoscopy of GI Tract60
6.1.5. Pseudomembranous colitis
Pseudomembranes are pathognomonic of pseudomembranous colitis (Clostridium difficile
associated colitis) but are not found in all cases. Clostridium difficiletoxins cause cytoskele‐
ton disruption causing shallow ulcerations which exude serum proteins and inflammatory
cells forming pseudomembranes. Endoscopic findings include raised yellow or off-white
plaques up to 2 cm in diameter scattered over the colorectal mucosa which cannot be re‐
moved by lavage. These lesions are discrete but may become confluent plaques in more ad‐
vanced cases. The other colonic findings are edema, erythema, and inflammation with or
without pseuodomembranes [56].
Figure 16. Pseudomembranous colitis- pseudomembranes(pointed by arrows)
6.1.6. Diverticular disease of colon
Diverticula are outpouching of mucosa through the muscle wall of the colon. Colonic diver‐
ticula are most frequent source of hematochezia followed by angiodysplasia and inflamma‐
tory bowel disease (IBD) [55]. Approximately 95% diverticulosis is noted in descending and
sigmoid colon. The prevalence increases with age, from less than 5 % at age nearly two-
third by age 80.The diverticular bleed presents as painless, acute hematochezia which is ar‐
terial in origin occurring at dome or neck of the diverticulum. About 60 % of diverticular
bleeds occurs in left colon, however angiography study recognizes diverticular bleeding
more often in the right colon. Bleeding stops spontaneously in 80% cases [55].
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Figure 17. Diverticulosis of colon (pointed by the arrows)
 
6.1.7. Arteriovenous malformations or Angiodysplasia
Angiodysplasia are detected in about 3-12% cases of lower GI bleeding.Most patients are
asymptomatic and overt bleeding occurs in presence of coagulopathy or platelet dysfunc‐
tion.They are mainly found as multiple lesions in the right colon, appearing as red, circum‐
ferential lesions measuring from one millimeter to a few centimeter. The incidence increases
with age.
Multiple telagiectasias in pale mucosa can also be seen in case of radiation induced proctop‐
athy which occurs following radiation therapy for prostatic carcinoma [55].
 
6.1.8. Inflammatory bowel disease
Endoscopic findings in ulcerative colitis (UC) are mucosal erythema and edema with loss
vascular pattern. Granularity of mucosa with friability, spontaneous bleeding and ulcers are
also seen. Some of patients of UC have focal inflammation around the appendiceal orifice
that is not contiguous with disease elsewhere in the colon which is known as "cecal patch".It
is important to obtain adequate mucosal biopsies to help distinguish Crohn'sileocolitisfrom
pan-ulcerative colitis with backwash ileitis (UC with distal ileum involvement).
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Figure 18. Ulcerative colitis- friable colon mucosa
Endoscopy in Crohns disease reveals aphthous ulcers, cobble stoning or skip lesions .A nor‐
mal rectum supports the diagnosis of Crohn's disease, since UC always involves the rectum.
The presence of normal vasculature adjacent to affected tissue is seen in Crohn's disease,
while loss of vascularity and friability is more typical of UC [57].
6.1.9. Hemorrhoids
Hemorrhoids are clusters of veins, smooth muscle and connective tissue lined by the normal
epithelium of the anal canal. They are categorized into internal and external hemorrhoids.
These categories are anatomically separated by the dentate (pectinate) line. External hemor‐
rhoids are hemorrhoids covered by squamous epithelium below the dentate line, where as
internal hemorrhoids are lined with colonic columnar epithelium proximal to dentate line.
Internal hemorrhoids are not supplied by somatic sensory nerves and therefore cannot cause
pain.Internal hemorrhoids are classified in 4 degrees by the Goligher classification (Table 1).
They are best viewed on retroflexed view on flexible endoscopy [58].
First degree Bleeds but donot prolapse
Second degree Prolapse but spontaneously reduce
Third degree Prolapse but require manual reduction
Fourth degree Unable to reduce
Table 1. Stains used in chromoendoscopy
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Figure 19. Internal hemorrhoids on retroflexed view
External hemorrhoidal veins are found circumferentially under the anoderm and are inner‐
vated by cutaneous nerves that supply the perianal area. Symptoms may occur anywhere
around the circumference of the anus [58].
6.1.10. Melanosis coli
Deposition of pigment in the intestinal mucosa is commonly observed on endoscopy, espe‐
cially within the colon. Electron microscopy has shown that this pigment is not melanin at
all, but lipofuscin deposition in macrophages of colon mucosa. Herbal remedies or anthra‐
quinone containing laxatives are often implicated. The pigment intensity is not uniform, be‐
ing more intense in the cecum and proximal colon compared to the distal colon. Colorectal
adenomas do not contain the melanin-like pigmentation. The association of adenomas with
melanosis coli can be explained by the ease of detection of even tiny polyps as white spots
within a dark-colored colonic mucosa [59]. The condition is benign requiring no treatment.
Figure 20. Melanosis coli – colon polyp noted (pointed by an arrow)
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6.1.11. Solitary rectal ulcer syndrome
Solitary rectal ulcer syndrome (SRUS) is a rare disorder of defecation presenting as bleeding
per rectum.The term SRUS is a misnomer, as 34% of the endoscopic findings are multiple
lesions. Endoscopic findings include mucosal ulcerations, polypoid lesions or simply erythe‐
ma. It is a rare and poorly understood disorder that occurs in people with chronic constipa‐
tion [60]. Treatments for solitary rectal ulcer syndrome range from changing diet and fluid
intake to surgery.
6.1.12. Stercoral ulcer
Stercoral ulceration is the loss ofbowel integrity from the pressure effects of inspissated fe‐
ces. It usually occurs in constipated and bedridden patients. Because of associated diseases
in the population at risk, perforation and hemorrhage are the principal complications result‐
ing in a mortality exceeding 50%. Endoscopically, it appears as an isolated lesion in the rec‐
tosigmoid area [61].
6.1.13. Colorectal cancer
Colorectal cancer presents commonly as abdominal pain, hematochezia, change of bowel
habits, anemia, or weight loss. Early diagnosis depends on routine screening. Colonoscopy
is the single best diagnostic test in symptomatic individuals, since it can localize and biopsy
lesions throughout the large bowel, detect synchronous neoplasms, and remove polyps. Air
contrast barium enema (BE), supplemented with flexible sigmoidoscopy, is also used to
evaluate symptomatic patients.
Figure 21. Colon cancer (pointed by an arrow)
Most colon cancers are adenocarcinomas which can be detected on colonoscopy and is un‐
doubtedly the single best diagnostic test in symptomatic individuals since it can localize and
biopsy lesions throughout the large bowel, detect synchronous neoplasms, and remove pol‐
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yps.Endoscopically,lesions may appear as circular proliferating,exophytic or stenosing le‐
sions and uncommonly as plaque like, flat discoid mass with slight depression or ulcer [52].
The likelihood of detection of colorectal cancer can be enhanced by novel methods like chro‐
moendoscopy, narrow band imaging, confocal laser endomincroscopy and high resolution
and high maginification endoscopy (described later).
7. Novel and adjunct methods with endoscopy
It is shown that certain flat adenomaswith subtle dysplastic and early neoplastic changes are
missed with white light endoscopy as they as they are too small,flat or depressed to be detected.
This has led to the development of techniques that compliment conventional endoscopic
methods and help in detection of subtle GI lesions by enhancing the image by high magnifi‐
cation or high definition. Image enhanced endoscopy technology can either be dye based
(Chromoendoscopy), equipment based (Narrow band imaging), or electronic based [62].
7.1. Chromoendoscopy
Chromoendoscopy involves the topical application of various stains or pigments to subtle GI
lesions to improve tissue localization and characterization resulting in targeted biopsies of
those lesions. The mucosa is pretreated with a mucolytic agent to remove excess mucus from
the mucosal surface. Most commonly 10 % N-acetylcysteine is used. Targeted spraying via a
spray catheter is performed for colon polyps and entire surface is stained inthe evaluation
Barrett’s esophagus. Glucagon is administered just before spraying to decrease contractions
and uneven spraying.It is considered to be a safe and nontoxic procedure [63]. The table below
describes various stains used in various conditions with their side effects (Table 2).
Stains Conditions Side effects
Methylene Blue Esophagus: Barrett’s mucosa/Post ablation to find Barrett’s
mucosa.
Gastric: Intestinal metaplasia
Colon:Chronic ulcerative colitis
Harmless , transient blue green
discoloration of urine and feces
Toluidine blue Esophagus: Squamous cell cancer None reported
Lugol’s solutionEsophagus: Squamous dysplasia and early squamous cell
carcinoma,
Retrosternal burning and nausea
which can be treated with
application of 5% sodium thiosulfate
which can neutralize residual iodine.
Avoided in patients with Iodine
hypersensitivity and hyperthyroidism
Indigo carmine Colon : Colorectal neoplasia,chronic ulcerative colitis None reported
Table 2. Stains used in chromoendoscopy
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Chromoendoscopy has been shown to detected higher number of lesions per patient com‐
pared with narrow band imaging (NBI), autofluorescence, or white light colonoscopy [64]. It
is an inexpensive, safe and relatively easy to perform but it is not standardized and is sub‐
ject to observer interpretation.
7.2. Narrow band imaging
Conventional white light endoscopy uses full visible wavelength (red-green-blue) to pro‐
duce an image. On the other hand narrow band imaging uses special filters which increase
relative intensity of the blue band thus enhancing the image quality. NBI used along with
magnifying endoscopy allows the analysis of thesurface architecture of the epithelium (pit
pattern) and theanalysis of the vascular network resulting in better characterization of dis‐
tinct types of gastrointestinal epithelia (e.g. intestinal metaplasia in Barret’s esophagus),as
well as the disorganization of the vascular pattern ininflammatory disorders and the irregu‐
lar pit pattern in earlyneoplastic lesions of the esophagus, stomach and largebowel [65].
The NBI generates a darker field of view than white light and allows adequate inspection of
the mucosal surface. The tip of the endoscope needs to be closer to the mucosa.The presence
of bile and blood strongly absorb narrow band light thus obscuring the view under NBI. The
NBI images are not yet standardized. There are no reported complications with NBI [66].
7.3. Confocal Laser Endomicroscopy
Canfocal Laser Endomicroscopy (CLE) is new imaging modality of GI endoscopy which al‐
lows in vivo imaging of the mucosal layer at cellular and subcellular resolution making in
vivo histology possible during endoscopy. CLE is based on the principle of illuminating a
tissue with a low-power laser and then detecting fluorescent light reflected from the tissue.
To illuminate the tissue, an exogenousagent ??is applied topically or systemically. Most
commonly used agent is intravenous fluorescein sodium which highlights the extracellular
matrix enabling confocal imaging. The laser is focused at a specific depth and only light re‐
flected back from that plane is refocused and able to pass through the pinhole confocal aper‐
ture. As a result, scattered light from above and below the plane of interest is not detected,
increasing special resolution. The area being examined is scanned in the horizontal and ver‐
tical planes and an image is reconstructed. In this manner, microscopic imaging of biological
tissue in vivo is possible due to the high lateral resolution of confocal imaging. It helps in
differentiation of neoplastic from non-neoplastic polyps, for example, neoplastic lesion in
patients with Barrett's esophagus [67], or ulcerative colitis, differentiation of benign from
malignant biliary strictures.
Currently, there are two CLE systems used, probe based (confocal probe passes through the
accessory channel of a standard video-endoscope) and integrated endoscopy (CLE integrat‐
ed in the distal tip of endoscope).
More data is needed to support these modalities. In future, CLE will develop multicolor analysis
of several layers with 3-dimensional reconstruction allowing deeper penetration depth [68].
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7.4. High resolution and high magnification endoscopy
High-resolution imaging improves the ability to discriminate detail while magnification en‐
larges the image. Magnification endoscopy often utilizes a movable lens controlled by the
endoscopist to vary the degree of magnification(100X as compared with 30X in standard en‐
doscopy). Both high magnification and high-resolution endoscopes were designed to be
used in conjunction with chromoendoscopy. High-resolution and high-magnification endos‐
copy may enhance the diagnosis and characterization of some mucosal lesions and may de‐
tect changes in vascular architecture of patients with early esophageal cancer. Magnification
chromoendoscopy has been used to characterize Barrett’s esophagus, early gastric cancer
and villous atrophy [69]. The magnification endoscopy is simple, inexpensive, requiring no
special light processors.The disadvantages are lack of standardization and prolongation of
procedure time [70]. Whether high-resolution or high-magnification endoscopy will de‐
crease the need for endoscopic biopsy or increase the diagnostic yield of endoscopic proce‐
dures has not yet been determined [71,72].
7.5. Autofluoresence imaging
Autofluorense imaging utilizes changes in concentrations of endogenous fluorophores, for
example flavin adenine dinucleotide, collagenand nicotinamide adenine dinucleotide. The
video-endoscopy adds green and red reflectance improving the image quality.The dysplas‐
tic tissue there is lack of fluorescence due to lack of collagen resulting in increased red and
decreased green fluorescence.It has been shown useful in detection of dysplasia in Barrett’s
esophagus and early esophageal cancer but there is insufficient data to support its routine
clinical use [62].
7.6. Endocytoscopy
Endocystoscopy is a new imaging method which provides combination which combines
chrmoendoscopy with ultra-high magnification catheter which is passed through the work‐
ing channel of the endoscope [73]. Unlike confocal endomicroscopy, it provides images in
color but is limited to superficial layer. It has been shown to give accurate results which are
almost comparable with histological results.The diagnosis based on endocytoscopic imaging
is subject to interpretation,and there is no validated criteria regarding tissue diagnosis and
differentiation for various GI conditions.
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